Compare Home Depot Inc (HD) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Home Depot Inc vs Novavax Inc — how do they compare? Home Depot Inc trades at $329.49 (market cap $332.08B), while Novavax Inc trades at $8.03 (market cap $1.30B). The key difference: Home Depot Inc is far larger — about 255.4× Novavax Inc's market cap, and Home Depot Inc pays a 2.8% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| HD | NVAX | |
|---|---|---|
Market Cap | $332.08B | $1.30B |
Sector | Consumer Cyclical | Health |
52-Week High | $423.42 | $11.19 |
52-Week Low | $297.51 | $6.22 |
Enterprise Value | $393.64B | $800.50M |
Dividend Yield | 2.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Home Depot (HD) trades at $331.77, down 2.1% today, with a bearish technical signal and mixed earnings history. The stock shows strong profitability with a 128.38% ROE and 8.41% net margin, but faces weakening profit margins and high valuation multiples. Recent news highlights institutional trading activity and concerns over housing market headwinds.
The outlook remains cautious due to technical weakness and margin pressure, though analyst consensus is bullish with a $370.59 price target. Key risks include rising mortgage rates impacting demand, while opportunities lie in Pro segment growth and dividend stability. The stock trades near support at $330, requiring monitoring of Q2 2026 earnings for direction.
Novavax (NVAX) trades at $7.86, down 4.26% on the day amid a bearish technical signal, though it has beaten earnings estimates for the last three quarters. The company reported $1.12 billion in revenue for 2025 with a net income of $440.30 million, yet faces negative shareholder equity and cash flow challenges. Recent news highlights stock volatility and shareholder dissent at the AGM, while analyst consensus remains largely bullish with a $14.00 price target.
The outlook for NVAX hinges on sustaining profitability and managing cash burn, with significant upside potential per analyst targets but substantial risks from negative equity, competitive pressures, and reliance on vaccine demand. Investors must weigh the high volatility and financial health concerns against the optimistic Wall Street ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
